Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca To Work With Belgian Diagnostics Firm On Lung Cancer Test

29th Nov 2018 10:12

LONDON (Alliance News) - Belgium-based diagnostics firm Biocartis Group NV on Thursday unveiled an agreement with AstraZeneca PLC in which the two will work to improve the speed of lung cancer be Read More

TOP NEWS: AstraZeneca Gets Orphan Drug Designation For Fasenra

26th Nov 2018 08:21

LONDON (Alliance News) - AstraZeneca PLC said Monday the US Food & Drug Administration has granted orphan drug designation to Fasenra for the treatment of eosinophilic granulomatosis with a to Read More

Redx Pharma Posts Large Annual Loss, Appoints Astra Executive As CFO

19th Nov 2018 13:07

LONDON (Alliance News) - Redx Pharma PLC on Monday posted a large loss due to the absence of a big exceptional disposal gain seen a year before and said that it has appointed James Mead as its new Read More

Consort Appoints Former AstraZeneca Executive As Chairman Designate

6th Nov 2018 09:16

LONDON (Alliance News) - Drug delivery devices manufacturer Consort Medical PLC said Tuesday it has appointed Chris Brinsmead as non-executive director and chairman designate of the will join the Read More

TOP NEWS: AstraZeneca Sells Medicine Rights For USD350 Million

6th Nov 2018 08:14

LONDON (Alliance News) - Pharmaceutical firm AstraZeneca PLC said on Tuesday it has agreed to sell its rights to the medicines Alvesco, Omnaris and Zetonna to Switzerland-based Covis Pharma BV for Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

1st Nov 2018 15:59

Friday 2 November Paddy Power BetfairQ3 ResultsTP ICAPQ3 Year & Copthorne 5 Traffic 6 Read More

UPDATE: AstraZeneca Gives More Details On Grunenthal Rights Deal

31st Oct 2018 11:42

LONDON (Alliance News) - Pharmaceutical company AstraZeneca PLC on Wednesday provided more information on its prescription medicine rights agreement with Grunenthal Group, including the book value Read More

TOP NEWS: AstraZeneca Sells Regional Rights To Nexium And Vimovo

30th Oct 2018 08:57

LONDON (Alliance News) - AstraZeneca PLC on Tuesday said it has divested regional prescription medicine rights for two of its drugs to German pharma company Grunenthal Group.FTSE 100-listed Read More

LONDON MARKET PRE-OPEN: BP Profit Up; Restaurant Group Buys Wagamama

30th Oct 2018 07:42

LONDON (Alliance News) - Stocks in London on Tuesday are seen building on Monday's strong gains following broadly positive trading in Asia overnight, as BP reported a sharp rise Read More

TOP NEWS: AstraZeneca Reports Positive Results From Lynparza Study

22nd Oct 2018 08:38

LONDON (Alliance News) - AstraZeneca PLC on Sunday said its Lynparza drug substantially reduced the risk of disease progression or death in patients with ovarian cancer.The drug, Lynparza, Read More

TOP NEWS: US FDA Grants Orphan Drug Status To AstraZeneca's Lynparza

16th Oct 2018 07:55

LONDON (Alliance News) - AstraZeneca PLC on Tuesday said the US Food & Drug Administration has granted orphan drug designation to Lynparza for the treatment of pancreatic cancer accounts for a Read More

LONDON MARKET PRE-OPEN: Bellway Boosts Payout; Meggitt Revenue Upgrade

16th Oct 2018 07:36

LONDON (Alliance News) - Stock prices in London are set to open softer on Tuesday, with focus in the UK on the latest jobs data and any Brexit developments ahead of Wednesday's summit in early UK Read More

TOP NEWS: AstraZeneca Sells Cheplapharm Rights For Atacand In Europe

1st Oct 2018 07:56

LONDON (Alliance News) - AstraZeneca PLC on Monday said it agreed to sell commercial rights for Atacand and Atacand Plus in Europe to Cheplapharm Arzneimittel GmbH.Atacand is a receptor for Read More

AstraZeneca Non-Executive Director Candidate Withdraws From Role

28th Sep 2018 16:40

LONDON (Alliance News) - FTSE 100-listed pharmaceutical giant AstraZeneca PLC said on Friday that Non-Executive Director candidate Joseph Peter has pulled out of his candidacy for the decision was Read More

Circassia Narrows Half Year Loss Through AstraZeneca Collaboration

27th Sep 2018 09:57

LONDON (Alliance News) - Circassia Pharmaceuticals PLC on Thursday said its loss narrowed in the first half of the year due mainly to its collaboration with pharmaceutical giant AstraZeneca pharma Read More

TOP NEWS: AstraZeneca's Farxiga Meets Primary Endpoint In Phase Three

24th Sep 2018 08:11

LONDON (Alliance News) - FTSE 100 pharmaceutical giant AstraZeneca PLC reported Monday positive results from its phase three DECLARE-TIMI 58 cardiovascular outcomes trial for Farxiga, or the on up Read More

PRESS: AstraZeneca CEO Warns Of Medicine Shortages In No-Deal Brexit

24th Sep 2018 06:36

LONDON (Alliance News) - AstraZeneca PLC Chief Executive Officer Pascal Soriot has warned of widespread shortages of medicines if Britain fails to agree a customs deal with the EU, the Sunday such Read More

AstraZeneca's Asthma Drug Fasenra Maintains Effectiveness Over 2 Years

18th Sep 2018 17:48

LONDON (Alliance News) - AstraZeneca PLC on Tuesday said the most recent trial of Fasenra showed that the asthma drug was as effective at reducing adverse events over a two-year period as it was a Read More

European Markets Finish Mixed On Global Trade Concerns

17th Sep 2018 17:07

BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets fluctuated between small gains and losses throughout Monday's session and ended the day with mixed results. Investors in Read More

AstraZeneca PT010 Trial Meets Eight Out Of Nine Endpoints

17th Sep 2018 11:50

LONDON (Alliance News) - AstraZeneca PLC said Sunday its trial of PT010 triple combination therapy in chronic obstructive pulmonary disease met eight of the nine primary lung function KRONOS Phase Read More

FTSE 100 Latest

Value10,149.01

Change22.23